PanOptica Investors

24 investors on Angel Roster list PanOptica in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States and the United Kingdom.

Investors are matched on the company name in their portfolio, so companies that share the name PanOptica can appear together.

Investors listed
24
With verified email
42%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 24 PanOptica investors

The most complete profiles first. Showing 24 of 24.

  • Christoph LengauerVerified

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Verified email available

  • Craig MuirVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Verified email available

  • Eugene HillVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 64 more

    Verified email available

  • Jack KenneyVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more

    Contact details available

  • Paul LaVioletteVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 63 more

    Verified email available

  • Robert TepperVerified

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Verified email available

  • Tom FlynnVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more

    Verified email available

  • Elizabeth Blake SchwertVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more

    Verified email available

  • Mike RossVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more

    Verified email available

  • Noreen RizviVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Verified email available

  • Abbie Celniker

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 54 more

    Contact details available

  • Cary Pfeffer

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

  • George Xu

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

  • Gregory Madden

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 63 more

    Contact details available

  • Houman Ashrafian

    Venture Capital, Investor · United Kingdom

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 64 more

    Contact details available

  • Mark Levin

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceEducation

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

  • Michael Balmuth

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 64 more

    Contact details available

  • Neil Exter

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

  • Brent Faduski

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more

    Contact details available

  • Carl Culicchia

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more

    Contact details available

  • Kelly Moynihan

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

  • Walter Kowtoniuk

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

  • William Motley

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

  • Dan BurgessVerified

    Angel/Individual · United States

    Health CareBiotechnologyTherapeutics

    Portfolio: Celerion, PanOptica, Ocular Therapeutix

    Verified email available

Frequently asked questions

How many PanOptica investors are on Angel Roster?

Angel Roster lists 24 PanOptica investors. 10 of them (42%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (23), Private Equity Firms (10) and Angel Investors (1). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do PanOptica investors invest in?

Among those that list a stage, the most common are Seed (15).

Where are PanOptica investors based?

Most are based in the United States (23) and the United Kingdom (1).

Which companies have PanOptica investors backed?

The most-backed portfolio companies among them are Cibiem, Inc. (23), Soffio Medical (23), Rhythm Metabolic (12), Editas Medicine (12) and MOMA Therapeutics (12).

How do I contact PanOptica investors?

Create a free Angel Roster account to search and filter all 24, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.